The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Ned-170: A combination anti-cancer therapy targeting late stage, heavily pre-treated solid tumor malignancies.

Edward Graeme  Garmey

Employment - CMO Consulting, Inc.

Consulting or Advisory Role - Aldeyra Therapeutics; Bicycle Therapeutics; Genzada Pharmaceuticals; ImmuneSensor Therapeutics; NED Biosystems; Novita Pharmaceuticals

Kristan  Meetze

Employment - NED Biosystems

Bridget  Martell

Employment - Juniper Pharmaceuticals

Leadership - NED Biosystems

Stock and Other Ownership Interests  - Juniper Pharmaceuticals